Annual Cash & Cash Equivalents
$41.06 M
-$80.52 M-66.23%
31 December 2023
Summary:
Aura Biosciences annual cash & cash equivalents is currently $41.06 million, with the most recent change of -$80.52 million (-66.23%) on 31 December 2023. During the last 3 years, it has risen by +$23.67 million (+136.09%). AURA annual cash & cash equivalents is now -72.45% below its all-time high of $149.06 million, reached on 31 December 2021.AURA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$25.41 M
-$4.67 M-15.52%
30 September 2024
Summary:
Aura Biosciences quarterly cash and cash equivalents is currently $25.41 million, with the most recent change of -$4.67 million (-15.52%) on 30 September 2024. Over the past year, it has dropped by -$30.18 million (-54.29%). AURA quarterly cash and cash equivalents is now -82.96% below its all-time high of $149.06 million, reached on 31 December 2021.AURA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AURA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -66.2% | -54.3% |
| 3 y3 years | +136.1% | -69.0% |
| 5 y5 years | - | - |
AURA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.5% | +136.1% | -83.0% | at low |
| 5 y | 5 years | -72.5% | +136.1% | -83.0% | +46.1% |
| alltime | all time | -72.5% | +136.1% | -83.0% | +46.1% |
Aura Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $25.41 M(-15.5%) |
| June 2024 | - | $30.07 M(+14.4%) |
| Mar 2024 | - | $26.28 M(-36.0%) |
| Dec 2023 | $41.06 M(-66.2%) | $41.06 M(-26.1%) |
| Sept 2023 | - | $55.58 M(+16.5%) |
| June 2023 | - | $47.73 M(+24.0%) |
| Mar 2023 | - | $38.49 M(-68.3%) |
| Dec 2022 | $121.58 M | $121.58 M(+99.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $61.11 M(+13.5%) |
| June 2022 | - | $53.85 M(-50.3%) |
| Mar 2022 | - | $108.38 M(-27.3%) |
| Dec 2021 | $149.06 M(+757.0%) | $149.06 M(+82.2%) |
| Sept 2021 | - | $81.83 M(-11.2%) |
| June 2021 | - | $92.20 M(+430.1%) |
| Dec 2020 | $17.39 M(-46.4%) | $17.39 M |
| Dec 2019 | $32.45 M | - |
FAQ
- What is Aura Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aura Biosciences?
- What is Aura Biosciences annual cash & cash equivalents year-on-year change?
- What is Aura Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aura Biosciences?
- What is Aura Biosciences quarterly cash and cash equivalents year-on-year change?
What is Aura Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of AURA is $41.06 M
What is the all time high annual cash & cash equivalents for Aura Biosciences?
Aura Biosciences all-time high annual cash & cash equivalents is $149.06 M
What is Aura Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, AURA annual cash & cash equivalents has changed by -$80.52 M (-66.23%)
What is Aura Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AURA is $25.41 M
What is the all time high quarterly cash and cash equivalents for Aura Biosciences?
Aura Biosciences all-time high quarterly cash and cash equivalents is $149.06 M
What is Aura Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, AURA quarterly cash and cash equivalents has changed by -$30.18 M (-54.29%)